ALLOCLAE AT BODYLUXE CHICAGO
A ready-to-use structural adipose filler — when you don’t have enough fat to transfer
AlloClae is a ready-to-use structural adipose filler made from donated human fat tissue that has been processed into a sterile matrix for injectable volume where fat naturally exists. It is not living fat transferred from your own liposuction harvest, not a silicone implant, and not stem-cell therapy. At BodyLuxe in Chicago, we treat it as one candidacy branch when donor fat is scarce — not a marketing substitute for surgery.
Ready-to-use
Off-the-shelf sterile packs (typically 12.5 cc and 25 cc) — ambient storage until the sterile barrier opens.
No harvest needed
No liposuction donor site when lean anatomy or a no-harvest preference makes grafting impractical.
Structural adipose
Intact non-viable adipocytes + ECM for cushioning where fat naturally exists — not HA gel, not stem-cell therapy.
WHAT IT IS
What is AlloClae made of?
AlloClae is a sterile, hydrated human adipose allograft: donated cadaveric fat tissue processed so the product contains non-viable intact adipocytes plus extracellular matrix, triglycerides, and connective tissue. It is designed for immediate structural volume in the subcutaneous plane. It does not rely on living donor cells growing inside you, and it is not a hyaluronic acid gel.
Tiger Aesthetics Medical distributes AlloClae; donor eligibility and release follow tissue banking rules (RegenTX Partners per the package insert). Terminal sterilization and processing claims (reduced free-oil fraction, minimized DNA) are manufacturer labeling for safety framing, not a zero-risk promise.
Clinically, the useful mental model is structure first. The preserved three-dimensional adipose architecture is meant to provide cushioning and support right away, with host remodeling described in preclinical work over subsequent months.
Editorial distinction: AlloClae is not Renuva (a different allograft adipose matrix often used in smaller soft-tissue volumes). AlloClae retains intact non-viable adipocyte structure for larger localized body contour units—do not use the names interchangeably.
HARVEST VS ALLOGRAFT
How is AlloClae different from fat transfer (and fat grafting)?
Autologous fat transfer (also called fat grafting) moves living fat from where you have excess to where you want volume after liposuction harvest, processing, and grafting. AlloClae is an off-the-shelf processed donor tissue product with no harvest site. Prefer your own fat when donor inventory and goals align; discuss AlloClae when lean anatomy, GLP-1 volume loss, or refusal of harvest makes grafting impractical for localized goals.
At BodyLuxe, FormSculpt® awake liposuction and fat transfer remain the backbone when donor fat and goals align. AlloClae does not replace that pathway. It answers a different consult question: Can we add soft tissue structure without taking fat from somewhere else?
For breasts specifically, AlloClae is better framed as modest contour or soft-volume refinement (cleavage, upper pole, rippling camouflage in selected cases) than as a cup-size replacement for implants.
AlloClae vs fat transfer vs implants — at a glance
| Decision factor | AlloClae | FormSculpt® / autologous fat transfer | Breast implants |
|---|---|---|---|
| Source of volume | Processed donor adipose allograft | Your own harvested fat | Device implant |
| Harvest / lipo required | No | Yes | No |
| Typical goal fit | Localized contour, irregularities, modest soft volume | Soft volume where donor fat allows; can stage larger plans | Predictable size change / shape structure |
| Regulatory class (US framing) | Section 361 HCT/P tissue product | Surgical grafting of autologous tissue | FDA-regulated devices |
| Reversible like HA? | No hyaluronidase “dissolve” | Grafted fat is living tissue once taken | Surgical removal / exchange |
| Downtime character | Often lighter, in-office pathway for many plans | Harvest + graft recovery | Surgical recovery |
Who might be a candidate for AlloClae, and who usually is not?
Candidates are usually patients with a localized soft-tissue deficit where fat naturally exists, limited or no harvestable donor fat, or a clear preference to avoid liposuction harvest. Poor fits include expectations of full surgical BBL projection, severe skin laxity needing excision, active infection, or requests to place tissue where native adipose does not exist.
Often worth discussing
Lean patients without donor fat; post-GLP-1 / post-weight-loss soft deflation when the issue is volume more than hanging skin; liposuction irregularities; hip dips seeking smoother silhouette; selected breast soft-tissue refinement; modest in-office no-harvest goals.
Usually not a solo AlloClae plan
Hundreds-of-cc surgical BBL-scale projection; significant skin excess needing excision; cellulite dimples without releasing tethered bands; active infection or placement outside homologous adipose territory (per IFU); commodity-injector shopping without surgeon judgment on plane and volume realism.
Package-insert guardrails: no active infection; no placement where native adipose does not exist; lidocaine combinations not evaluated per labeling; single patient, single use, with allograft tracking.
Not sure whether AlloClae or your own fat fits? Map it with Dr. Farrugia.
AREAS & EXPECTATIONS
Can AlloClae be used for breasts, buttocks, and hip dips?
Manufacturer clinical application lists include gluteal contouring, hip dips, liposuction irregularities, and breast contour uses (asymmetry, rippling, cleavage refinement / modest breast-augmentation–scale soft fill). That does not make every request appropriate or turn AlloClae into a surgical BBL. Volume realism and subcutaneous-only planning decide the case.
Hip dips are the most common ask: smoother silhouette without a full surgical gluteal graft—not a “non-surgical BBL” for everyone. Buttocks: localized cushioning and shape polish, not hundreds-of-cc BBL projection; packs (commonly 12.5 cc / 25 cc) mean plans map total cc and may stage. Breasts: modest soft volume and contour irregularities; not implant-level size change. Disclose prior fat-based treatment to mammography teams—oil cysts and calcifications can appear, similar to fat-transfer counseling.
BodyLuxe Results — breasts, buttocks & hip dips
These are BodyLuxe Results for the body areas where AlloClae is most often discussed — breasts, buttocks, and hip dips — shown as filtered galleries from our fat-transfer and contour library (breast-fat-transfer procedure; buttocks-and-hip-dips body area). Expect subtle soft-tissue fill and smoother contours in mapped areas—not dramatic surgical projection.
Honest catalog note: there are currently 0 AlloClae-tagged cases in the BodyLuxe Results library. When AlloClae cases are published, they should appear here. Until then, related BodyLuxe fat-transfer and contour results are shown for anatomical context — not as AlloClae outcomes.
Breast fat transfer Results
BodyLuxe fat-transfer Results in the breast area — related contour context for AlloClae breast discussions. These are not AlloClae-tagged cases.
Buttocks & hip dips Results
BodyLuxe contour Results for buttocks and hip dips — related context for AlloClae lower-body discussions. These are not AlloClae-tagged cases.
Manufacturer educational examples (not BodyLuxe Results)
Secondary supplement only: manufacturer / official brand educational before-and-afters for volume realism. These are not BodyLuxe patient results and must not be read as our AlloClae gallery.
Hip-dip volume realism (brand Instagram): official @alloclae educational before-and-after framing ~25 cc per hip dip. Patient photos shared via brand Instagram; credited to treating physician in caption only — not a BodyLuxe case and not a Sources citation.
LONGEVITY
How long does AlloClae last, and is it permanent?
Longevity is still being characterized in humans. Preclinical work and early clinical experience suggest lasting structural presence with remodeling over months, but published multi-year volumetric imaging trials for AlloClae are not mature enough to support invented retention percentages. Plan for individual variation and possible staged touch-ups.
Manufacturer language describes lasting but variable results. Early trade anecdotes are not BodyLuxe guarantees. We will not invent Chicago retention percentages, claim implant-like permanence, or promise on-demand dissolve—unlike HA, there is no hyaluronidase reversal.
If longevity certainty is your top priority and you have donor fat, autologous transfer still has the longer clinical track record as your living tissue. See how long fat transfer lasts.
REGULATION & SAFETY
Is AlloClae FDA-cleared or FDA-approved, and is it safe?
AlloClae is regulated as a Section 361 Human Cell/Tissue Product (HCT/P) under 21 CFR Part 1271. It is not FDA-approved or FDA-cleared as a drug or medical device. Safety is real-tissue transplant safety: screening, sterile processing, homologous use, and known adverse-event possibilities, not a “zero risk injectable” slogan.
The IFU frames homologous use as cushioning and support where fat naturally exists. Marketing that says “FDA approved” as if this were a drug or device pathway is imprecise—those phrases are not interchangeable.
What BodyLuxe will not say: FDA approved; FDA cleared; guaranteed pathogen-free; safer than BBL as a blanket claim; stem-cell therapy. Real risks include nodules/cysts, infection, hematoma, allergic responses, and theoretical residual disease-transmission risk. For surgical BBL context, see ASPS / Aesthetic Society gluteal fat grafting safety statements. FDA consumer guidance also states conventional dermal fillers are not approved for large-scale breast/buttock body contouring—so AlloClae must be framed as an HCT/P tissue product, not “butt filler” slang.
How much does AlloClae cost?
Patients often cannot find a trustworthy AlloClae price online; volume mapping belongs in consult, not a viral sticker. Cost depends on how many cubic centimeters your map needs, which areas you treat (breasts, buttocks, hip dips, irregularities), and whether sessions are staged—not a single national package price. Manufacturer guidance: discuss volume with your provider. Out-of-market per-syringe examples in national press or YouTube comments are literacy only, not BodyLuxe fees.
At BodyLuxe in Chicago, we compare total-episode economics at a complimentary consult: in-office allograft versus OR + anesthesia + lipo harvest + transfer when donor fat fits. Small localized fill can favor an off-the-shelf unit; large projection with usable donor fat often favors autologous transfer. We do not invent Chicago dollar amounts or area-specific online fee quotes—personalized estimates belong in consult after anatomy mapping.
What should I expect for downtime compared with awake fat transfer?
Many AlloClae plans are positioned as in-office treatments with return toward usual activity in roughly 24–48 hours per consumer education, without a liposuction harvest site. Awake FormSculpt® fat transfer adds harvest recovery, compression, and lipo activity limits. Exact downtime still depends on areas, volume, and healing.
Expect swelling and tenderness. “Little downtime” is not “no risk.” Match expectations to goal size—not to viral “non-surgical BBL” content.
How do I choose AlloClae vs FormSculpt® fat transfer in Chicago?
Choose by goal magnitude, donor-fat map, skin quality, cost/cc realism, and harvest tolerance. Usable donor fat and soft living volume → FormSculpt® transfer first-line. Lean, post-GLP, or no-harvest localized goals → AlloClae enters the conversation. Severe laxity or implant-level size change redirects the plan.
Lean / post-GLP-1 volume loss
After GLP-1 medications, major weight loss, or athletic leaning-out, soft tissue often deflates in hips, buttocks, and breasts. Volume-only deficits may suit grafting or AlloClae; laxity-dominant problems need lifts first. If you are not removing loose skin surgically, care is usually about skin health, weight stability, compression/support habits, and realistic expectations—not an injectable that “tightens” hanging folds. Stabilize weight before elective volume—we will not sell AlloClae as a fix for hanging skin.
AlloClae vs hyaluronic acid (and vs BBL framing)
HA gels are temporary, often reversible ~1 cc-class gels—not adipose architecture for structural body contouring. AlloClae does not dissolve on demand and is not a “non-surgical BBL” synonym. Dramatic projection still points to surgical fat grafting when donor inventory exists.
Safety, imaging, and who should inject
Homologous subcutaneous placement, conservative volumes, and staging beat brand slogans. Breast plans need mammography disclosure. Surgeon judgment in a surgeon-owned practice is part of the product.
Chicago consult path
You consult directly with Dr. Daniel J. Farrugia at BodyLuxe. We map donor fat, examine skin, and decide whether AlloClae, FormSculpt® transfer, a staged combination, or another plan is honest medicine.
If you previously read our article on using somebody else’s fat for transfer, note: raw living donor fat for cosmetic grafting is not the same as a regulated AlloClae structural adipose allograft.
Related reading: Breast fat transfer in Chicago · Fat transfer hub · Fat transfer vs breast implants · About Dr. Farrugia
Meet us on Michigan Avenue
BodyLuxe is a surgeon-owned boutique practice in Chicago. Your complimentary consult starts with a Health Profile, then time with Dr. Farrugia — not a commodity injector lane.
Frequently asked questions
What is AlloClae?
AlloClae is a processed donor adipose tissue product used as an injectable structural filler for localized volume where fat naturally exists—ready to use without harvesting your own fat. It is not living autologous fat transfer and not a hyaluronic acid gel.
Is AlloClae the same as fat transfer?
No. Fat transfer uses your own fat after liposuction harvest. AlloClae is an off-the-shelf donor tissue allograft with no harvest site. They can share a consult menu for different candidacy profiles, but they are not interchangeable.
How much does AlloClae cost?
Online AlloClae pricing is usually opaque: cost depends on cc map, areas, and staging—not a national sticker. At BodyLuxe we compare total-episode economics (allograft vs harvest + transfer) at a complimentary consult and do not invent online fee quotes.
How long does AlloClae last?
Human longevity data are still maturing. Early experience describes lasting but variable results with remodeling over months. We do not invent retention percentages or promise permanence; staged touch-ups may be realistic.
Is AlloClae permanent?
No honest plan calls AlloClae implant-permanent. Results are lasting and variable—not guaranteed forever—and unlike HA there is no on-demand dissolve.
Is AlloClae FDA approved?
AlloClae is regulated as a Section 361 Human Cells, Tissues, and Cellular and Tissue-Based Product (HCT/P) under 21 CFR Part 1271. That is not the same as FDA approval or FDA clearance as a drug or medical device. Marketing that says “FDA approved” as if it were a device/drug pathway is imprecise.
Is AlloClae safe?
It is a screened human tissue product with real possible adverse events (infection, nodules/cysts, hematoma, allergic responses, theoretical disease-transmission risk). Safety depends on candidacy, sterile technique, homologous placement, and surgeon judgment—not “natural” slogans.
What are AlloClae side effects?
Possible events include nodules/cysts, pain, infection, hematoma, allergic or immune responses (including anaphylaxis), skin discoloration, and theoretical residual disease-transmission risk. Breast plans need imaging disclosure—fat-based materials can be associated with oil cysts or calcifications.
Is AlloClae a non-surgical BBL?
No. A surgical BBL combines liposuction harvest with large-volume fat grafting under modern safety standards. AlloClae can refine buttocks and hip dips without harvest, but at realistic allograft volumes—not as a drop-in for dramatic surgical projection. “AlloClae BBL” search language is common; the medicine is not the same.
Does BodyLuxe offer AlloClae in Chicago?
Availability and candidacy are confirmed at consultation so we match inventory, protocol, and anatomy. The complimentary consult is with Dr. Daniel J. Farrugia at our surgeon-owned Chicago practice.
Is AlloClae made from donor (cadaveric) fat?
Yes. It is screened, processed human donor (cadaveric) adipose tissue under tissue-banking rules—not living fat taken from a friend or another patient in the room. YouTube commenters asking “where does it come from?” deserve that plain answer. Some patients accept allografts; others want only their own fat. Both preferences belong in the consult.
Is AlloClae spelled Alloclae or Allo Clae?
The product name used in BodyLuxe published copy is AlloClae (manufacturer camelCase trademark: alloClae™). Search variants such as Alloclae or Allo Clae usually refer to the same product.
How much is one syringe of AlloClae?
Syringe/cc pricing is not a fixed national sticker; AlloClae is often planned in cc maps (common manufacturer pack sizes include 12.5 cc and 25 cc), and total cost depends on volume, areas, and staging. BodyLuxe does not invent online per-syringe Chicago prices — we quote at a complimentary consult after mapping your anatomy.
Is AlloClae better than Renuva?
They are related but not interchangeable. Renuva is typically framed as an allograft adipose matrix (scaffold after cellular material is removed), often for smaller soft-tissue volumes. AlloClae retains intact (non-viable) adipocyte structure and is positioned for larger localized body-contour units. Choice is anatomy and goal size, not a brand contest — and we do not cite other practices’ marketing pages.
Is AlloClae safer than a BBL?
Different procedure classes. A surgical BBL combines liposuction harvest with large-volume fat grafting. AlloClae can refine buttocks/hip dips without harvest at realistic volumes, but it is not automatically a “safer BBL.” Plane, volume, and surgeon judgment still govern risk.
Is AlloClae worth it?
“Worth it” depends on candidacy: lean/post-GLP patients wanting localized soft volume without harvest often benefit from the consult; dramatic surgical projection usually needs FormSculpt® fat transfer or another plan. We answer that with Dr. Farrugia—not viral before/after promises.
How long does it take for AlloClae to settle?
Early swelling and tenderness are expected; manufacturer/consumer education often frames return toward usual activity in roughly 24–48 hours for many in-office plans, but settling and remodeling continue over months. Exact timelines are case-specific.
Does AlloClae feel like fat or like an implant?
AlloClae is meant to feel soft like soft tissue, not like a firm silicone implant. Early swelling can feel firmer; as it settles, the goal is natural cushioning. Exact feel varies by plane, volume, and anatomy—we set tactile expectations in consult, not from a comment thread.
Can fat from a breast fat transfer migrate to another body area?
Living fat that takes stays part of the recipient site; it does not typically “migrate” later as a free blob to a distant area. Patients more often notice weight-related volume change, partial resorption, oil cysts, or contour irregularity—counseling we also give for FormSculpt® transfer. AlloClae is a processed donor allograft, not a living graft, so autologous-migration myths should not be copy-pasted onto it.
Can AlloClae fix loose skin after Ozempic / GLP-1 without surgery?
No. AlloClae adds volume; it does not excise hanging skin. After GLP-1 loss, laxity-dominant problems need lifts or staged contouring; soft deflation with decent skin quality may suit AlloClae or autologous transfer. We separate volume vs laxity at the complimentary consult.
Sources
- alloClae consumer site (Tiger)
- Tiger Aesthetics — AlloClae Structural Adipose Filler
- AlloClae IFU L-032 Rev. 07 (PDF)
- Tiger BioSciences — AlloClae product page
- Tiger Aesthetics news — AlloClae launch / GenesisTissue investment
- Fanniel et al., Bioengineering 2025 (DOI)
- Fanniel et al., PMC full text
- FDA guidance: HCT/Ps — Minimal Manipulation and Homologous Use
- 21 CFR Part 1271 (HCT/Ps)
- ASPS / societies — Gluteal Fat Grafting joint safety statement
- Gluteal Fat Grafting Safety Advisory (PDF, Aug 2022)
- ISAPS-endorsed patient safety statement on gluteal fat grafting (PDF)
- Allure — What Is Alloclae?
- Plastic Surgery Practice — fat-based injectables interview
- MTF Biologics — Renuva (product contrast only)
- FDA Consumer Update — Dermal filler do’s and don’ts (no fillers for body contouring)
- ASPS — Fat transfer breast augmentation safety
- The Aesthetic Society — Gluteal Fat Grafting Safety Advisory
- PubMed PMID 42697558 — Autologous fat grafting breast SR/MA (abstract-only until full text)
Medical review
This article was medically reviewed by Daniel J. Farrugia, MD, PhD, FACS.
BodyLuxe is a surgeon-owned boutique practice in Chicago. Educational content supports, but does not replace, an in-person consultation. Individual results vary. AlloClae is a Section 361 HCT/P tissue product; it is not FDA-approved or FDA-cleared as a drug or device.
Product, lifestyle, and educational before-and-after imagery courtesy of Tiger Aesthetics / alloClae.com / Tiger BioSciences and official @alloclae Instagram. Manufacturer and brand Instagram educational examples are labeled in captions and are not BodyLuxe patient results. Hip-dip Instagram example patient photos courtesy Dr. Johnny Franco via @alloclae (caption credit only — not a Sources citation; not a BodyLuxe case). Manufacturer/brand educational examples above are labeled separately and are not BodyLuxe Results. BodyLuxe Results blocks above are filtered fat-transfer/contour galleries (breast-fat-transfer; buttocks-and-hip-dips), not AlloClae cases; AlloClae-tagged cases will appear when published (currently 0).
COMPLIMENTARY CONSULTATION
Ready to map whether AlloClae — or your own fat — is the honest next step?
Book a complimentary consultation with Dr. Farrugia. Start with your Health Profile (about 5 minutes) on our consultation page, then choose a time. The right answer might still be your own fat, a lift, implants, or no procedure yet.